SHD MANAGEMENT, LLC

Thesis

SHD Management, LLC, also known as Scientific Health Development (SHD), is a venture capital firm established in 2006 and based in Dallas, Texas. The firm's core focus is on early-stage investments within the medical technology (medtech) sector, specifically targeting U.S.-based companies at the pre-seed, seed, seed+, Series A, and Series A+ stages. Their investment strategy prioritizes innovative and easily adoptable technologies that aim to improve patient outcomes while reducing economic burdens. SHD prefers to lead investment rounds, with typical investments ranging from $500,000 to $50 million, and a preferred check size of $2.5 million. The firm's sector focus is broad within healthcare, encompassing Health Care, Life Science, Health & Wellness, Eyewear, Health Insurance, Diabetes, Electronic Health Record (EHR), Health Diagnostics, Home Health Care, Medical, Medical Device, mHealth, Pharmaceutical, Therapeutics, Biopharma, Biotechnology, and HealthTech. SHD also utilizes Qualified Small Business (QSBS) tax advantages to enhance investment appeal. The firm manages multiple funds, with SHD Management, LLC reporting $60,917,756 in AUM as of March 20, 2026.

Related lists

• Pre-seed Healthcare investors
• Seed-stage Healthcare investors
• Series A Healthcare investors